NeoImmuneTech

NeoImmuneTech is a company listed under the stock ticker 950220 (KR).

View the org chart displaying its 21 main executives

Most searched biographies at NeoImmuneTech

• Luke Oh, Chief Executive Officer
• Soo-Hyoung Kang, Director
• Byoung Jo Kang, Director

Popular executive movements at NeoImmuneTech

• Luke Oh, who was President, is promoted to Chief Executive Officer  (posted on April 3 2024).
• Luke Oh has joined the company as President  (posted on January 16 2024).

Create your alert
to follow the executive moves at NeoImmuneTech.

NeoImmuneTech has 2,290 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Aardvark Therapeutics has just announced a $85 Million fundraising (posted on May 12 2024).
• Bluejay Therapeutics has just announced a $182 Million fundraising (posted on May 12 2024).
• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by NeoImmuneTech

Social media about NeoImmuneTech

• NeoImmuneTech on Wikipedia, Google News & Yahoo Finance
• NeoImmuneTech on LinkedIn, Twitter & YouTube

Contact by email its executives including Byung Ha Lee

Call NeoImmuneTech at +1 240...

View the org chart

Register to receive your alert

Report an error